Peptides and Anti-Doping: Which Ones Are Actually Banned for Competitive Athletes

For anyone subject to drug testing — Olympic and national federation athletes, and increasingly some collegiate and even amateur competitive contexts — understanding which peptides and hormone therapies actually appear on the World Anti-Doping Agency (WADA) prohibited list matters well beyond the general population health discussion these compounds usually get.

Growth Hormone Secretagogues: Broadly Prohibited

WADA's prohibited list includes growth hormone and growth hormone-releasing peptides as a class under Section S2 (peptide hormones, growth factors, and related substances) — this covers GHRH analogs like CJC-1295 and sermorelin, and ghrelin-receptor agonists like ipamorelin, essentially the entire GH-secretagogue category discussed for body composition and recovery purposes. These are prohibited at all times, in and out of competition, for tested athletes, not just on competition day.

TRT: Prohibited Without a Therapeutic Use Exemption

Testosterone and its esters fall under WADA's S1 category (anabolic agents) and are prohibited at all times for tested athletes. A legitimate medical diagnosis of hypogonadism doesn't automatically clear an athlete to use TRT while competing — it requires an approved Therapeutic Use Exemption (TUE), a formal application and medical review process through the relevant anti-doping authority, not simply a prescription from a treating physician. Using TRT without an approved TUE, even with a legitimate diagnosis and prescription, is a doping violation under the applicable rules.

GLP-1 Drugs: A More Recent, Evolving Classification

GLP-1 receptor agonists like semaglutide and tirzepatide are not classified as performance-enhancing in the traditional sense (they don't build muscle or directly enhance athletic performance), but WADA has been actively reviewing their status given the potential for rapid weight loss and body composition changes to matter in weight-class sports specifically. Athletes in bodies governed by anti-doping rules should check the current-year prohibited list directly, since this is an area of active regulatory attention rather than a long-settled classification the way anabolic steroids or growth hormone secretagogues are.

Peptides Marketed for Recovery and Healing

Some peptides marketed for injury recovery, including certain growth-factor-adjacent compounds, also fall under WADA's broader S2 category covering peptide hormones and growth factors, meaning 'it's for recovery, not performance' isn't necessarily a distinction the anti-doping rules themselves recognize — classification tends to follow the compound and mechanism, not the athlete's stated intent for using it.

Why This Matters Beyond Elite Sport

Drug testing has expanded well beyond Olympic and professional sport into many collegiate programs and some amateur competitive leagues, meaning the practical relevance of WADA's prohibited list extends further down the competitive ladder than people often assume — a compound being legal to purchase and legal to use in a general medical context doesn't mean it's compliant with a specific sport's testing rules.

Practical Takeaway

Growth hormone secretagogues and testosterone/TRT are both broadly prohibited for tested athletes without an approved TUE, regardless of legitimate medical rationale behind their use. GLP-1 drugs occupy a more recently and actively evolving regulatory space. Any competitive athlete subject to testing should check the current WADA prohibited list and pursue a formal TUE process rather than assuming a valid prescription alone provides compliance.